Tonghua Dongbao Pharmaceutical Co Ltd (600867) — Cash Flow Quality Index
Tonghua Dongbao Pharmaceutical Co Ltd (600867) has a Cash Flow Quality Index of 0.06x as of September 2025. Operating cash flow of CN¥62.99 Million is below net income of CN¥984.48 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Tonghua Dongbao Pharmaceutical Co Ltd (600867) long-term investment share to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Tonghua Dongbao Pharmaceutical Co Ltd Cash Flow Quality Index (1998–2025)
Historical Cash Flow Quality Index for Tonghua Dongbao Pharmaceutical Co Ltd across 26 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Tonghua Dongbao Pharmaceutical Co Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Tonghua Dongbao Pharmaceutical Co Ltd (1998–2025)
Year-by-year earnings quality comparison for Tonghua Dongbao Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see how much is Tonghua Dongbao Pharmaceutical Co Ltd worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.57x | CN¥689.23 Million | CN¥1.22 Billion | ▼ -23.4% |
| 2023 | 0.74x | CN¥861.52 Million | CN¥1.17 Billion | ▲ +35.2% |
| 2022 | 0.55x | CN¥863.09 Million | CN¥1.58 Billion | ▼ -37.1% |
| 2021 | 0.87x | CN¥1.13 Billion | CN¥1.31 Billion | ▼ -32.3% |
| 2020 | 1.28x | CN¥1.19 Billion | CN¥930.32 Million | ▼ -9.9% |
| 2019 | 1.42x | CN¥1.15 Billion | CN¥809.64 Million | ▲ +36.1% |
| 2018 | 1.05x | CN¥876.94 Million | CN¥838.92 Million | ▼ -8.6% |
| 2017 | 1.14x | CN¥961.19 Million | CN¥840.10 Million | ▲ +0.8% |
| 2016 | 1.14x | CN¥725.76 Million | CN¥639.21 Million | ▲ +88.9% |
| 2015 | 0.60x | CN¥294.58 Million | CN¥490.06 Million | ▼ -19.3% |
| 2014 | 0.74x | CN¥205.89 Million | CN¥276.54 Million | ▼ -39.6% |
| 2013 | 1.23x | CN¥221.06 Million | CN¥179.46 Million | ▼ -62.2% |
| 2012 | 3.26x | CN¥194.32 Million | CN¥59.65 Million | ▲ +2247.2% |
| 2011 | -0.15x | CN¥-55.07 Million | CN¥362.98 Million | ▼ -116.4% |
| 2010 | 0.93x | CN¥160.40 Million | CN¥173.36 Million | ▼ -62.3% |
| 2009 | 2.46x | CN¥166.20 Million | CN¥67.68 Million | ▲ +18.5% |
| 2008 | 2.07x | CN¥92.31 Million | CN¥44.56 Million | ▲ +29.6% |
| 2007 | 1.60x | CN¥120.94 Million | CN¥75.69 Million | ▼ -86.6% |
| 2006 | 11.90x | CN¥158.00 Million | CN¥13.27 Million | ▲ +132.2% |
| 2005 | 5.13x | CN¥92.23 Million | CN¥17.99 Million | ▲ +330.2% |
| 2003 | 1.19x | CN¥45.51 Million | CN¥38.18 Million | ▲ +65.3% |
| 2002 | 0.72x | CN¥31.99 Million | CN¥44.38 Million | ▼ -81.0% |
| 2001 | 3.79x | CN¥117.73 Million | CN¥31.04 Million | ▲ +525.4% |
| 2000 | 0.61x | CN¥29.12 Million | CN¥48.02 Million | ▲ +145.6% |
| 1999 | -1.33x | CN¥-95.09 Million | CN¥71.55 Million | ▲ +44.5% |
| 1998 | -2.39x | CN¥-216.98 Million | CN¥90.66 Million | — |